Sanae Teshigawara
Overview
Explore the profile of Sanae Teshigawara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sue M, Watanabe M, Inoue A, Katayama A, Teshigawara S, Matsushita Y, et al.
Clin Case Rep
. 2025 Feb;
13(2):e70173.
PMID: 39902194
This report describes the first case of maturity-onset diabetes in young (MODY) with HNF1B mutation started administration of the dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, tirzepatide. A...
2.
Ueno A, Onishi Y, Mise K, Yamaguchi S, Kanno A, Nojima I, et al.
BMJ Open Diabetes Res Care
. 2024 May;
12(3).
PMID: 38816205
Introduction: ACE cleaves angiotensin I (Ang I) to angiotensin II (Ang II) inducing vasoconstriction via Ang II type 1 (AT1) receptor, while ACE2 cleaves Ang II to Ang (1-7) causing...
3.
Teshigawara S, Tone A, Katayama A, Imai Y, Tahara T, Senoo M, et al.
Diabetol Int
. 2023 Jul;
14(3):262-270.
PMID: 37397907
Introduction: To investigate changes in insulin requirements over time in patients who underwent hepatectomy and pancreatectomy with perioperative glycemic control by an artificial pancreas (STG-55). Materials And Methods: We included...
4.
Teshigawara S, Tone A, Katayama A, Imai Y, Tahara T, Senoo M, et al.
Diabetol Int
. 2023 Jul;
14(3):271.
PMID: 37397903
[This corrects the article DOI: 10.1007/s13340-023-00623-3.].
5.
Nunoue T, Yamaguchi S, Teshigawara S, Katayama A, Nakatsuka A, Eguchi J, et al.
Sci Rep
. 2021 Sep;
11(1):18611.
PMID: 34521981
No abstract available.
6.
Mise K, Imamura M, Yamaguchi S, Watanabe M, Higuchi C, Katayama A, et al.
Front Cardiovasc Med
. 2021 Jun;
8:668059.
PMID: 34109226
Although various biomarkers predict cardiovascular event (CVE) in patients with diabetes, the relationship of urinary glycan profile with CVE in patients with diabetes remains unclear. Among 680 patients with type...
7.
Nunoue T, Yamaguchi S, Teshigawara S, Katayama A, Nakatsuka A, Eguchi J, et al.
Sci Rep
. 2021 Mar;
11(1):5991.
PMID: 33727589
The adipose tissue is regarded as an endocrine organ and secretes bioactive adipokines modulating chronic inflammation and oxidative stress in obesity. Gal-9 is secreted out upon cell injuries, interacts with...
8.
Senoo M, Tone A, Imai Y, Watanabe S, Kaneto M, Shimomura Y, et al.
Acta Med Okayama
. 2021 Mar;
75(1):103-107.
PMID: 33649621
A 43-year-old male with type 2 diabetes, under treatment with 5 mg/day of dapagliflozin, was referred to our hospital with upper left abdominal pain and marked hypertriglyceridemia (triglycerides [TGs], 5,960...
9.
Kotake K, Tone A, Watanabe S, Senoo M, Kaneto M, Imai Y, et al.
Intern Med
. 2021 Feb;
60(14):2251-2254.
PMID: 33583891
Distigmine bromide is widely used to treat neurogenic bladder and causes cholinergic crisis, a serious side effect. We herein report about a patient with distigmine bromide-induced cholinergic crisis complicated by...
10.
Nojima I, Eikawa S, Tomonobu N, Hada Y, Kajitani N, Teshigawara S, et al.
Sci Rep
. 2020 Sep;
10(1):14928.
PMID: 32913271
The metabolic changes and dysfunction in CD8 + T cells may be involved in tumor progression and susceptibility to virus infection in type 2 diabetes (T2D). In C57BL/6JJcl mice fed...